# US 6,730,497 B2 · Process for preparing cephalosporanic acid derivatives using β-ketoacid derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,497 B2
- Document ID: US6730497B2
- Status: Granted
- Kind: B2
- Application number: 10/125,458
- Filed: 2002-04-19
- Published: 2003-06-05
- Granted: 2004-05-04
- Earliest claimed: 2001-04-19
- Assignees: Bioferma Murcia S.A.
- Inventors: Alvaro Sánchez-Ferrer; José Aniceto López-Más; Francisco García-Carmona
- Web page: https://patentgrep.com/patent/US6730497B2

## CPC

- C07D 501/00: Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: [IMAGE cpc-sch-C07D-0993.gif] , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

A process for preparing cephalosporanic acid derivatives comprises the steps of enzymatically converting a 3-thiolated cephalosporin C compound of formula III: into a 3-thiolated-α-ketoadipyl-7-aminocephalosporanic acid derivative of formula IV: wherein R is a heterocyclic group comprising at least a nitrogen atom. Compounds of formula IV are used in the preparation of cephalosporin C antibiotics and derivatives thereof.

## Claims

### Claim 1

A process for preparing cephalosporanic acid derivatives comprising the steps of:
enzymatically converting a 3-thiolated cephalosporin C compound of formula III:
into a 3-thiolated-α-ketoadipyl-7-aminocephalosporanic acid derivative of formula IV:
wherein R is a heterocyclic group comprising at least a nitrogen atom.

### Claim 2 (depends on 1)

The process as claimed in claim 1 wherein the compound of formula III is enzymatically converted into a compound of formula IV by an immobilised enzyme system.

### Claim 3 (depends on 2)

The process as claimed in claim 2 wherein the enzyme system comprises co-immobilised D-Amino acid oxidase and catalase.

### Claim 4 (depends on 3)

The process as claimed in claim 3 wherein the enzymatic conversion is carried out in the presence of molecular oxygen, at a pressure of 1 to 5 bar absolute, a pH of from 6.5 to 8.0 and at a temperature of from 15 to 30° C. for a period of from 30 mins to 180 mins.

### Claim 5 (depends on 1)

The process as claimed in claim 1 comprising the step of separating the enzyme system from the reaction mixture.

### Claim 6 (depends on 1)

The process as claimed in claim 1 including the step of purifying the compound of formula IV.

### Claim 7 (depends on 6)

The process as claimed in claim 6 wherein the compound is purified using an adsorption column.

### Claim 8 (depends on 1)

The process as claimed in claim 1 wherein the enzymes are co-immobilised using a suitable cross-linker agent in a suitable solid support.

### Claim 9 (depends on 8)

The process as claimed in claim 8 wherein the enzymes are in the form of crystals of a size suitable for use as a biocatalyst.

### Claim 10 (depends on 1)

The process as claimed in claim 1 wherein the enzymatic processes are carried out while maintaining the enzyme in dispersion in an aqueous substrate solution.

### Claim 11 (depends on 1)

The process as claimed in claim 1 wherein the enzymatic process is carried out in a column.

### Claim 12 (depends on 1)

The process as claimed in claim 1 including the step of recovering the enzyme for reuse.

### Claim 13 (depends on 5)

The process as claimed in claim 5, wherein the step of separating the enzyme system from the reaction mixture is performed by filtration.

### Claim 14 (depends on 1)

The process as claimed in claim 1 wherein R is a heterocyclic group comprising at least one nitrogen atom and optionally a sulphur or oxygen atom.

### Claim 15 (depends on 14)

The process as claimed in claim 14 wherein R is a heterocyclic group selected from any one or more of the group comprising thienyl, diazolyl, tetrazolyl, thiazolyl, triazinyl, oxazolyl, oxadiazolyl, pyridyl, pirimidinyl, benzothiazolyl, benzimidazolyl, benzoxazolyl, or any derivative thereof, preferably 5-methyl-1,3,4-thiadiazol-2-yl, 1-methyl-1H-tetrazol-5-yl or 1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl.
